Thermo Fisher Scientific TMO
NYSE TMO
$659.18 +10.75 (+1.66%)
As of: Sep 17, 2026 · 3:59 PM EDT

Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2013 - 2026)

Thermo Fisher Scientific's (TMO) quarterly Income from Non-Controlling Interests came in at $5.0 million in Q2 2026, up 150.0% on a YoY basis from $2.0 million in Q2 2025, and little changed quarter-over-quarter from $5.0 million in Q1 2026.

Analysis

Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends

Thermo Fisher Scientific (TMO) has reported Income from Non-Controlling Interests for 9 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 150.0% year-over-year to $5.0 million; the trailing twelve-month figure through Jun 2026 stood at $21.0 million (changed N/A YoY), and the FY2025 full-year result was $17.0 million, up 466.67% from the prior year.
  • Income from Non-Controlling Interests was little changed at $5.0 million in Q2 2026 per TMO's latest filing, from $5.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $6.0 million in Q2 2024 and bottomed at -$24.0 million in Q4 2023.
  • Historically, Income from Non-Controlling Interests has averaged $58823.5 across 5 years, with a median of $4.0 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Income from Non-Controlling Interests plunged 1100.0% in 2023, then jumped 500.0% in 2024.
  • Over 5 years, Income from Non-Controlling Interests stood at -$2.0 million in 2022, then slumped by 1100.0% to -$24.0 million in 2023, then soared by 75.0% to -$6.0 million in 2024, then jumped by 200.0% to $6.0 million in 2025, then decreased by 16.67% to $5.0 million in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $5.0 million, $5.0 million, and $6.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 5.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 5.00 Mn
Mar 28, 2026 5.00 Mn
Dec 31, 2025 6.00 Mn
Sep 27, 2025 5.00 Mn
Jun 28, 2025 2.00 Mn
Mar 29, 2025 4.00 Mn
Dec 31, 2024 -6.00 Mn
Jun 29, 2024 6.00 Mn
Mar 30, 2024 4.00 Mn
Dec 31, 2023 -24.00 Mn
Sep 30, 2023 -20.00 Mn
Jul 1, 2023 1.00 Mn
Apr 1, 2023 3.00 Mn
Dec 31, 2022 -2.00 Mn
Oct 1, 2022 3.00 Mn
Jul 2, 2022 4.00 Mn
Apr 2, 2022 5.00 Mn
Dec 31, 2021 1.00 Mn
Oct 2, 2021 1.00 Mn
Jul 3, 2021 1.00 Mn